TLC BioSciences Corp. (TPEX:7924)
Taiwan · Delayed Price · Currency is TWD 331.50
+47.00 (16.52%)
At close: Sep 17, 2026
TLC BioSciences Market Cap
TLC BioSciences has a market cap or net worth of 44.28 billion as of September 17, 2026.
Market Cap
44.28B
Enterprise Value
43.52B
Revenue
78.44M
Ranking
n/a
PE Ratio
n/a
Stock Price
331.50
ChartMarket Cap Chart
Since June 26, 2026, TLC BioSciences's market cap has increased from 28.11B to 44.28B, an increase of 57.48%. That is a compound annual growth rate of 636.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2026 | 44.28B | 16.52% |
| Sep 16, 2026 | 38.00B | 1.07% |
| Sep 15, 2026 | 37.60B | 2.36% |
| Sep 14, 2026 | 36.73B | 1.48% |
| Sep 11, 2026 | 36.19B | -2.52% |
| Sep 10, 2026 | 37.13B | 12.10% |
| Sep 9, 2026 | 33.12B | -0.80% |
| Sep 8, 2026 | 33.39B | -4.21% |
| Sep 7, 2026 | 34.86B | -0.38% |
| Sep 4, 2026 | 34.99B | -2.60% |
| Sep 3, 2026 | 35.93B | 1.32% |
| Sep 2, 2026 | 35.46B | 2.91% |
| Sep 1, 2026 | 34.46B | 0.98% |
| Aug 31, 2026 | 34.12B | -3.95% |
| Aug 28, 2026 | 35.53B | -5.34% |
| Aug 27, 2026 | 37.53B | -0.53% |
| Aug 26, 2026 | 37.73B | 0.89% |
| Aug 25, 2026 | 37.40B | 1.27% |
| Aug 24, 2026 | 36.93B | 0.91% |
| Aug 21, 2026 | 36.60B | -3.86% |
| Aug 20, 2026 | 38.06B | -1.21% |
| Aug 19, 2026 | 38.53B | -2.20% |
| Aug 18, 2026 | 39.40B | 6.88% |
| Aug 17, 2026 | 36.86B | 15.00% |
| Aug 14, 2026 | 32.05B | 1.27% |
| Aug 13, 2026 | 31.65B | - |
| Aug 12, 2026 | 31.65B | 4.41% |
| Aug 11, 2026 | 30.32B | -1.30% |
| Aug 10, 2026 | 30.72B | 5.75% |
| Aug 7, 2026 | 29.05B | 0.69% |
| Aug 6, 2026 | 28.85B | 2.61% |
| Aug 5, 2026 | 28.11B | 0.24% |
| Aug 4, 2026 | 28.05B | -4.11% |
| Aug 3, 2026 | 29.25B | -7.01% |
| Jul 31, 2026 | 31.45B | 12.68% |
| Jul 30, 2026 | 27.91B | 6.91% |
| Jul 29, 2026 | 26.11B | -7.13% |
| Jul 28, 2026 | 28.11B | -1.41% |
| Jul 27, 2026 | 28.52B | -1.16% |
| Jul 24, 2026 | 28.85B | - |
| Jul 23, 2026 | 28.85B | -6.09% |
| Jul 22, 2026 | 30.72B | 6.48% |
| Jul 21, 2026 | 28.85B | 7.46% |
| Jul 20, 2026 | 26.85B | -8.01% |
| Jul 17, 2026 | 29.18B | -6.62% |
| Jul 16, 2026 | 31.25B | 1.08% |
| Jul 15, 2026 | 30.92B | 0.22% |
| Jul 14, 2026 | 30.85B | -5.91% |
| Jul 13, 2026 | 32.79B | -0.20% |
| Jul 9, 2026 | 32.86B | -1.80% |
| Jul 8, 2026 | 33.46B | -4.75% |
| Jul 7, 2026 | 35.13B | 8.68% |
| Jul 6, 2026 | 32.32B | -3.59% |
| Jul 3, 2026 | 33.52B | 48.52% |
| Jul 2, 2026 | 22.57B | -4.52% |
| Jul 1, 2026 | 23.64B | -8.05% |
| Jun 30, 2026 | 25.71B | -10.26% |
| Jun 29, 2026 | 28.65B | 1.90% |
| Jun 26, 2026 | 28.11B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| A-Top Health Biotech | 43.35B |
| HanchorBio | 19.79B |
| Elixiron Immunotherapeutics (Cayman) Limited | 19.47B |
| Intelligene | 7.80B |
| Tripartite Therapeutics | 5.54B |
| Uwell Biopharma | 5.19B |
| Obigen Pharma | 5.17B |
| Pet Pharm Biotech | 3.20B |